利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

17 条记录 (耗时 0.022 秒)

    Synthetic antigenic peptide derived from Hepatitis B surface antigen
    2.
    发明授权
    Synthetic antigenic peptide derived from Hepatitis B surface antigen 失效
    衍生自乙型肝炎表面抗原的合成抗原肽

    公开(公告)号：US4575495A

    公开(公告)日：1986-03-11

    申请号：US631661

    申请日：1984-07-17

    申请人： John Vnek ,  Alfred M. Prince ,  Hafeez Ikram

    发明人： John Vnek ,  Alfred M. Prince ,  Hafeez Ikram

    IPC分类号： A61K39/00 ,  C07K14/02 ,  A61K37/00

    CPC分类号： C07K14/005 ,  A61K39/00 ,  C12N2730/10122 ,  Y10S930/223

    摘要： There is disclosed a new synthetic peptide which evokes an immunological response. The synthetic peptide, moreover, interacts with antibodies to Hepatitis B surface antigen (HBsAG). Thus, the synthetic peptide is useful as an immunizing agent in a vaccine as an active component thereof where it serves to produce antibodies in vivo which are protective against Hepatitis B virus. The synthetic peptide of the invention comprises the following sequence of amino acids: Arg Trp Met Met Leu Arg Arg(I) and preferably has the following sequence: Gly Tyr Arg Trp Met Met Leu Arg Arg Phe Gly (II).

    摘要翻译： 公开了一种引起免疫应答的新型合成肽。 此外，合成肽与乙型肝炎表面抗原（HBsAG）的抗体相互作用。 因此，合成肽可用作疫苗中的免疫剂作为其活性成分，其用于在体内产生抗乙型肝炎病毒的抗体。 本发明的合成肽包含以下氨基酸序列：Arg Trp Met Met Leu Arg Arg（I），优选具有以下序列：Gly Tyr Arg Trp Met Met Leu Arg Arg Phe Gly（II）。

    Synthetic antigenic peptide derived from hepatitis B surface antigen
    3.
    发明授权
    Synthetic antigenic peptide derived from hepatitis B surface antigen 失效
    衍生自乙型肝炎表面抗原的合成抗原肽

    公开(公告)号：US4578217A

    公开(公告)日：1986-03-25

    申请号：US493904

    申请日：1983-05-12

    申请人： John Vnek ,  Alfred M. Prince ,  Hafeez Ikram

    发明人： John Vnek ,  Alfred M. Prince ,  Hafeez Ikram

    IPC分类号： A61K39/00 ,  C07K14/02 ,  C07K14/075 ,  A61K37/00

    CPC分类号： C07K14/005 ,  A61K39/00 ,  C12N2730/10122 ,  Y10S530/806 ,  Y10S930/223

    摘要： There is disclosed a new synthetic peptide which evokes an immunological response. The synthetic peptide, moreover, interacts with antibodies to hepatitis B surface antigen (HBsAg). Thus, the synthetic peptide is useful as an immunizing agent in a vaccine as an active component thereof where it serves to produce antibodies in vivo which are protective against hepatitis B virus. The synthetic peptide of the invention comprises the following sequence of amino acids: Arg Trp Met Met Leu Arg Arg (I) and preferably has the following sequence: Gly Tyr Arg Trp Met Met Leu Arg Arg Phe Gly (II).

    摘要翻译： 公开了一种引起免疫应答的新型合成肽。 此外，合成肽与乙型肝炎表面抗原（HBsAg）的抗体相互作用。 因此，合成肽可用作疫苗中的免疫剂作为其活性成分，其用于在体内产生抗乙型肝炎病毒的抗体。 本发明的合成肽包含以下氨基酸序列：Arg Trp Met Met Leu Arg Arg（I），优选具有以下序列：Gly Tyr Arg Trp Met Met Leu Arg Arg Phe Gly（II）。

    Large scale purification of hepatitis type B antigen using polyethylene glycol
    7.
    发明授权
    Large scale purification of hepatitis type B antigen using polyethylene glycol 失效
    使用聚乙二醇大规模纯化乙型肝炎抗原

    公开(公告)号：US3951937A

    公开(公告)日：1976-04-20

    申请号：US426825

    申请日：1973-12-20

    申请人： John Vnek ,  Alfred M. Prince

    发明人： John Vnek ,  Alfred M. Prince

    IPC分类号： C07K14/02 ,  C07G7/00

    CPC分类号： C07K14/005 ,  C12N2730/10122 ,  Y10S435/803 ,  Y10S530/806 ,  Y10S530/83

    摘要： Highly purified type B hepatitis antigen (HB Ag) is produced from fluid blood material containing such antigen by subjecting blood material containing naturally occurring HB Ag to a double precipitation with polyethylene glycol. In each precipitation, the pH of the fluid blood material is maintained at approximately 4.4 to 4.7 and a polyethylene glycol concentration of approximately 4.0 to 4.5 weight per cent is used. Particularly good results are obtained if the temperature of the material is maintained in the range of 0.degree. to 8.degree.C after the polyethylene glycol has been added. The antigen thus obtained may be further purified by absorption of impurities to hydroxy apatite, followed by isopycnic banding and zonal ultracentrifugation. Hydroxy apatite column chromatography is used to separate the purified antigen into three separate populations of particles.

    摘要翻译： 通过使含有天然存在的HB Ag的血液物质与聚乙二醇进行双重沉淀，由含有该抗原的流体血液物质制备高纯度乙型肝炎抗原（HB Ag）。 在每次沉淀中，流体血液物质的pH保持在约4.4至4.7，并且使用约4.0至4.5重量％的聚乙二醇浓度。 在加入聚乙二醇后，如果材料的温度保持在0〜8℃的范围内，则可获得特别好的结果。 由此获得的抗原可以通过将杂质吸收到羟磷灰石中进一步纯化，随后进行等环条带和带状超速离心。 羟磷灰石柱色谱用于将纯化的抗原分离成三个分开的颗粒群。

    Methods and systems for producing recombinant viral antigens
    8.
    发明申请
    Methods and systems for producing recombinant viral antigens 失效
    用于产生重组病毒抗原的方法和系统

    公开(公告)号：US20080193920A1

    公开(公告)日：2008-08-14

    申请号：US12077046

    申请日：2008-03-14

    申请人： Suzanne Zebedee ,  Genevieve Inchauspe ,  Marc S. Nasoff ,  Alfred M. Prince

    发明人： Suzanne Zebedee ,  Genevieve Inchauspe ,  Marc S. Nasoff ,  Alfred M. Prince

    IPC分类号： C12Q1/70

    CPC分类号： C07K14/005 ,  A61K38/00 ,  C12N2740/16222 ,  C12Q1/703 ,  Y10S436/82

    摘要： The present invention relates to recombinant expression vectors which express segments of deoxyribonucleic acid that encode recombinant HIV and HCV antigens. These recombinant expression vectors are transformed into host cells and used in a method to express large quantities of these antigens. The invention also provides compositions containing certain of the isolated antigens, diagnostic systems containing these antigens and methods of assaying body fluids to detect the presence of antibodies against the antigens of the invention.

    摘要翻译： 本发明涉及表达编码重组HIV和HCV抗原的脱氧核糖核酸的重组表达载体。 将这些重组表达载体转化到宿主细胞中并用于表达大量这些抗原的方法中。 本发明还提供含有某些分离的抗原的组合物，含有这些抗原的诊断系统和测定体液以检测针对本发明的抗原的抗体的存在的方法。

    Process for inactivating hepatitis B virus
    9.
    发明授权
    Process for inactivating hepatitis B virus 失效
    灭活乙型肝炎病毒的方法

    公开(公告)号：US4591505A

    公开(公告)日：1986-05-27

    申请号：US581528

    申请日：1984-02-21

    申请人： Alfred M. Prince

    发明人： Alfred M. Prince

    IPC分类号： A61K35/16 ,  A61L2/00 ,  C07K14/755

    CPC分类号： A61K35/16 ,  A61L2/0035 ,  A61L2/0088 ,  C07K14/755

    摘要： A mammalian blood plasma or plasma derivative substantially free of active hepatitis B or non-A, non-B viruses is disclosed, the plasma being characterized by the presence of factor VIII, the percent by weight of denatured factor VIII to the sum of undenatured factor VIII and denatured factor VIII being less than 50%. The plasma is sterilized by contact with a detergent, alcohol or ether, and mixtures thereof and preferably a mixture of detergent and ether, usually followed by removal of the viral sterilizing agent.

    摘要翻译： 公开了基本上不含活性乙型肝炎或非A非B型病毒的哺乳动物血浆或血浆衍生物，血浆的特征在于存在因子VIII，变性因子VIII的重量百分比与未变性因子的总和 VIII和变性因子VIII小于50％。 等离子体通过与洗涤剂，醇或醚及其混合物接触而灭菌，优选通过洗涤剂和醚的混合物灭菌，通常随后除去病毒灭菌剂。

    Method for detecting nanbv associated seroconversion
    10.
    发明申请
    Method for detecting nanbv associated seroconversion 审中-公开
    检测纳伏相关血清转化的方法

    公开(公告)号：US20090155772A1

    公开(公告)日：2009-06-18

    申请号：US12322370

    申请日：2009-01-29

    申请人： Suzanne Zebedee ,  Genevieve Inchauspe ,  Marc S. Nasoff ,  Alfred M. Prince

    发明人： Suzanne Zebedee ,  Genevieve Inchauspe ,  Marc S. Nasoff ,  Alfred M. Prince

    IPC分类号： C12Q1/70

    CPC分类号： C07K14/005 ,  A61K38/00 ,  C12N2740/16222 ,  C12Q1/703 ,  Y10S436/82

    摘要： The present invention relates to recombinant expression vectors which express segments of deoxyribonucleic acid that encode recombinant HIV and HCV antigens. These recombinant expression vectors are transformed into host cells and used in a method to express large quantities of these antigens. The invention also provides compositions containing certain of the isolated antigens, diagnostic systems containing these antigens and methods of assaying body fluids to detect the presence of antibodies against the antigens of the invention.

    摘要翻译： 本发明涉及表达编码重组HIV和HCV抗原的脱氧核糖核酸的重组表达载体。 将这些重组表达载体转化到宿主细胞中并用于表达大量这些抗原的方法中。 本发明还提供含有某些分离的抗原的组合物，含有这些抗原的诊断系统和测定体液以检测针对本发明的抗原的抗体的存在的方法。